<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221127056634N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-10-31</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of total extracts of Lactuca sativa seeds and Melissa officinalis leaves on dental anxiety</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of total extracts of Lactuca sativa seeds and Melissa officinalis leaves on dental anxiety of patients referring for dental extraction; A Randomized Double-blind clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-10-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>48</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/79755</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Random allocation of patients is done in two stages. In the first stage, patients are randomly assigned to one of the two treatment arms (lettuce seed or Melissa officinalis leave), and then in the second stage, two parts of each patient's mouth will be randomly assigned to drug and placebo treatment in each of the two treatment groups. Block randomization method is used with the aim of achieving groups of equal size in the first stage. The number of required blocks according to the total number of the estimated sample (48 patients) is 8 blocks, and the size of each block varies between 4,6 and 8. (2 blocks of 6, 3 blocks of 4 and 3 blocks of 8). In each block, according to the size specified for it, considering two treatment groups A (lettuce seeds), B (Melissa officinalis leaves), first all possible conditions are determined for the order of treatment allocation. For example, for blocks of size 4, the set of possible states for the order of allocation of the two desired treatments is considered including six orders AABB, ABAB, ABBA, BABA, BBAA and ABBA. Then by choosing one of the arrangements randomly from the set of all possible arrangements, the patients are allocated to two treatments A and B respectively. This pattern is repeated for other consecutive blocks as well until all the sample are randomly assigned to treatment groups. In the second stage, within each treatment group, the left and right parts of each patient's mouth (considering only one tooth in each part) were randomly selected by tossing a coin to one of the two treatment orders of the right tooth - drug treatment, left tooth - placebo (if the appearance heads) or left tooth - drug treatment, right tooth - placebo (if tails appears) are allocated, Blinding description: In order to blindness and not inform the patient about the received treatment, the capsules will have the same size and appearance, and the patient will not know the type of substance inside. Also, the statistician who analyzes the results will not know about the study groups of the patients.</study_design>
      <phase>3</phase>
      <hc_freetext>Dental anxiety.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group A: Lettuce seed-placebo group: In one session, the patient receives a capsule containing 100 mg of spray-dried total extract powder of Lactuca Sativa seeds (obtained from Marwarid Gharb Khorasan Pharmaceutical Company). In the next session, when the patient comes to have his/her opposite tooth extracted, he/she receives a capsule containing 100 mg of corn starch as placebo. (or vice versa depending on randomization). Intervention 2: Intervention group B: Melissa officinalis leaves-placebo group: In one session, the patient receives a capsule containing 100 mg of spray-dried total extract powder of Melissa officinalis leaves (obtained from Marwarid Gharb Khorasan Pharmaceutical Company). In the next session, when the patient comes to have his/her opposite tooth extracted, he/she receives a capsule containing 100 mg of corn starch as placebo. (or vice versa depending on randomization). Intervention 3: Control group: As explained, each patient is placed in one session in the intervention group and one session in the control group. (split-mouth design).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Mazdak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan University of Medical sciences, Hezarjerib st.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73461</zip>
        <telephone>+98 31 3668 8138</telephone>
        <email>alimazdak@res.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Rabbani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan University of Medical sciences, Hezarjerib st.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73461</zip>
        <telephone>+98 31 3668 8138</telephone>
        <email>rabbani@pharm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients over 18 years old
Patients referred for bilateral extraction of two molar or premolar teeth
Having a healthy mental state and the ability and informed consent to complete the questionnaire</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Taking CNS depressant and anxiolytic drugs such as benzodiazepines in the past fifteen days
Pregnancy or lactation
Continuous consumption of Sanabel Noma syrup or other lettuce seed products during the past month
Continuous consumption of Nejabal capsule or other Melissa officinalis products during the last month
History of allergy to lettuce or its seeds or Melissa officinalis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group A: Lettuce seed-placebo group: In one session, the patient receives a capsule containing 100 mg of spray-dried total extract powder of Lactuca Sativa seeds (obtained from Marwarid Gharb Khorasan Pharmaceutical Company). In the next session, when the patient comes to have his/her opposite tooth extracted, he/she receives a capsule containing 100 mg of corn starch as placebo. (or vice versa depending on randomization)</i_keyword>
      <i_keyword>Intervention group B: Melissa officinalis leaves-placebo group: In one session, the patient receives a capsule containing 100 mg of spray-dried total extract powder of Melissa officinalis leaves (obtained from Marwarid Gharb Khorasan Pharmaceutical Company). In the next session, when the patient comes to have his/her opposite tooth extracted, he/she receives a capsule containing 100 mg of corn starch as placebo. (or vice versa depending on randomization)</i_keyword>
      <i_keyword>Control group: As explained, each patient is placed in one session in the intervention group and one session in the control group. (split-mouth design)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety score in the questionnaire. Timepoint: Half an hour before the intervention (taking medicine), After the tooth extraction procedure. Method of measurement: Modified Dental Anxiety Scale for Dental Extraction Procedure questionnaire.</prim_outcome>
      <prim_outcome>Heart rate. Timepoint: Half an hour before the intervention (taking medicine), After the tooth extraction procedure. Method of measurement: Pulse oximeter device.</prim_outcome>
      <prim_outcome>Blood oxygen saturation percentage. Timepoint: Half an hour before the intervention (taking medicine), After the tooth extraction procedure. Method of measurement: Pulse oximeter device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-04-14</approval_date>
        <contact_name>Research Ethics Committees of Schools of Pharmacy and Nutrition, Isfahan University of Medical Scien</contact_name>
        <contact_address>School of Pharmacy, Isfahan University of Medical Sciences, Hezar jerib st. Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
